Nasarre P - Search Results

1

The VEGF-regulated transcription factor HLX controls the expression of guidance cues and negatively regulates sprouting of endothelial cells.

Testori J, Schweighofer B, Helfrich I, Sturtzel C, Lipnik K, Gesierich S, Nasarre P, Hofer-Warbinek R, Bilban M, Augustin HG, Hofer E. Testori J, et al. Among authors: nasarre p. Blood. 2011 Mar 3;117(9):2735-44. doi: 10.1182/blood-2010-07-293209. Epub 2011 Jan 11. Blood. 2011. PMID: 21224470 Free PMC article.

2

Host-derived angiopoietin-2 affects early stages of tumor development and vessel maturation but is dispensable for later stages of tumor growth.

Nasarre P, Thomas M, Kruse K, Helfrich I, Wolter V, Deppermann C, Schadendorf D, Thurston G, Fiedler U, Augustin HG. Nasarre P, et al. Cancer Res. 2009 Feb 15;69(4):1324-33. doi: 10.1158/0008-5472.CAN-08-3030. Epub 2009 Feb 10. Cancer Res. 2009. PMID: 19208839 Free PMC article.

3

Semaphorin SEMA3F affects multiple signaling pathways in lung cancer cells.

Potiron VA, Sharma G, Nasarre P, Clarhaut JA, Augustin HG, Gemmill RM, Roche J, Drabkin HA. Potiron VA, et al. Among authors: nasarre p. Cancer Res. 2007 Sep 15;67(18):8708-15. doi: 10.1158/0008-5472.CAN-06-3612. Cancer Res. 2007. PMID: 17875711

4

Selective suppression of in vivo tumorigenicity by semaphorin SEMA3F in lung cancer cells.

Kusy S, Nasarre P, Chan D, Potiron V, Meyronet D, Gemmill RM, Constantin B, Drabkin HA, Roche J. Kusy S, et al. Among authors: nasarre p. Neoplasia. 2005 May;7(5):457-65. doi: 10.1593/neo.04721. Neoplasia. 2005. PMID: 15967098 Free PMC article.

5

ZEB1-responsive genes in non-small cell lung cancer.

Gemmill RM, Roche J, Potiron VA, Nasarre P, Mitas M, Coldren CD, Helfrich BA, Garrett-Mayer E, Bunn PA, Drabkin HA. Gemmill RM, et al. Among authors: nasarre p. Cancer Lett. 2011 Jan 1;300(1):66-78. doi: 10.1016/j.canlet.2010.09.007. Epub 2010 Oct 25. Cancer Lett. 2011. PMID: 20980099 Free PMC article.

6

Neuropilin-2 Is upregulated in lung cancer cells during TGF-β1-induced epithelial-mesenchymal transition.

Nasarre P, Gemmill RM, Potiron VA, Roche J, Lu X, Barón AE, Korch C, Garrett-Mayer E, Lagana A, Howe PH, Drabkin HA. Nasarre P, et al. Cancer Res. 2013 Dec 1;73(23):7111-21. doi: 10.1158/0008-5472.CAN-13-1755. Epub 2013 Oct 11. Cancer Res. 2013. PMID: 24121493 Free PMC article.

7

Semaphorin SEMA3F has a repulsing activity on breast cancer cells and inhibits E-cadherin-mediated cell adhesion.

Nasarre P, Kusy S, Constantin B, Castellani V, Drabkin HA, Bagnard D, Roche J. Nasarre P, et al. Neoplasia. 2005 Feb;7(2):180-9. doi: 10.1593/neo.04481. Neoplasia. 2005. PMID: 15802023 Free PMC article.

8

Semaphorin signaling in the immune system.

Potiron V, Nasarre P, Roche J, Healy C, Boumsell L. Potiron V, et al. Among authors: nasarre p. Adv Exp Med Biol. 2007;600:132-44. doi: 10.1007/978-0-387-70956-7_11. Adv Exp Med Biol. 2007. PMID: 17607952 Review.

9

Guidance molecules in lung cancer.

Nasarre P, Potiron V, Drabkin H, Roche J. Nasarre P, et al. Cell Adh Migr. 2010 Jan-Mar;4(1):130-45. doi: 10.4161/cam.4.1.10882. Epub 2010 Jan 7. Cell Adh Migr. 2010. PMID: 20139699 Free PMC article. Review.

10

ZEB1 Mediates Acquired Resistance to the Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer.

Yoshida T, Song L, Bai Y, Kinose F, Li J, Ohaegbulam KC, Muñoz-Antonia T, Qu X, Eschrich S, Uramoto H, Tanaka F, Nasarre P, Gemmill RM, Roche J, Drabkin HA, Haura EB. Yoshida T, et al. Among authors: nasarre p. PLoS One. 2016 Jan 20;11(1):e0147344. doi: 10.1371/journal.pone.0147344. eCollection 2016. PLoS One. 2016. PMID: 26789630 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

23 results

Search Page